Shares of Nu Skin Enterprises, Inc. (NYSE:NUS - Get Free Report) passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $7.10 and traded as high as $8.12. Nu Skin Enterprises shares last traded at $8.00, with a volume of 444,019 shares trading hands.
Analyst Upgrades and Downgrades
Separately, Wall Street Zen upgraded shares of Nu Skin Enterprises from a "hold" rating to a "buy" rating in a research note on Monday, May 12th.
View Our Latest Analysis on NUS
Nu Skin Enterprises Price Performance
The stock's fifty day moving average price is $7.39 and its 200-day moving average price is $7.12. The firm has a market cap of $444.20 million, a PE ratio of -11.24 and a beta of 0.95. The company has a debt-to-equity ratio of 0.29, a current ratio of 2.02 and a quick ratio of 1.29.
Nu Skin Enterprises (NYSE:NUS - Get Free Report) last released its quarterly earnings data on Thursday, May 8th. The company reported $0.23 earnings per share for the quarter, topping analysts' consensus estimates of $0.15 by $0.08. The company had revenue of $364.49 million for the quarter, compared to analyst estimates of $352.06 million. Nu Skin Enterprises had a positive return on equity of 6.99% and a negative net margin of 2.30%. As a group, equities analysts expect that Nu Skin Enterprises, Inc. will post 1.05 EPS for the current fiscal year.
Nu Skin Enterprises Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Wednesday, June 11th. Stockholders of record on Friday, May 30th were given a dividend of $0.06 per share. The ex-dividend date was Friday, May 30th. This represents a $0.24 dividend on an annualized basis and a dividend yield of 2.67%. Nu Skin Enterprises's dividend payout ratio (DPR) is presently -30.00%.
Insider Transactions at Nu Skin Enterprises
In other Nu Skin Enterprises news, Director Edwina D. Woodbury sold 4,532 shares of the business's stock in a transaction on Monday, June 2nd. The stock was sold at an average price of $8.44, for a total transaction of $38,250.08. Following the sale, the director directly owned 42,947 shares in the company, valued at approximately $362,472.68. The trade was a 9.55% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Steven Keith Hatchett purchased 6,500 shares of the stock in a transaction dated Wednesday, May 28th. The shares were purchased at an average price of $7.54 per share, with a total value of $49,010.00. Following the completion of the acquisition, the insider owned 162,065 shares of the company's stock, valued at approximately $1,221,970.10. This represents a 4.18% increase in their ownership of the stock. The disclosure for this purchase can be found here. Company insiders own 2.00% of the company's stock.
Institutional Trading of Nu Skin Enterprises
A number of hedge funds have recently added to or reduced their stakes in the business. Strs Ohio acquired a new position in shares of Nu Skin Enterprises during the 1st quarter valued at about $472,000. Goldman Sachs Group Inc. boosted its holdings in shares of Nu Skin Enterprises by 7.2% in the 1st quarter. Goldman Sachs Group Inc. now owns 1,319,885 shares of the company's stock valued at $9,582,000 after purchasing an additional 88,088 shares during the last quarter. Dynamic Technology Lab Private Ltd purchased a new stake in shares of Nu Skin Enterprises during the 1st quarter valued at $162,000. AQR Capital Management LLC boosted its holdings in Nu Skin Enterprises by 64.6% in the first quarter. AQR Capital Management LLC now owns 350,357 shares of the company's stock valued at $2,530,000 after acquiring an additional 137,475 shares during the last quarter. Finally, Amundi grew its holdings in shares of Nu Skin Enterprises by 18.8% during the 1st quarter. Amundi now owns 18,564 shares of the company's stock worth $127,000 after purchasing an additional 2,941 shares during the period. 82.84% of the stock is owned by institutional investors and hedge funds.
About Nu Skin Enterprises
(
Get Free Report)
Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.
Featured Articles
Before you consider Nu Skin Enterprises, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nu Skin Enterprises wasn't on the list.
While Nu Skin Enterprises currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
